| Cat. No. |
Product Name |
Information |
| PC-20935 |
NV914
FTSJ1 inhibitor
|
NV914 is a small molecule inhibitor of tRNA-specific 2′-O-methyltransferase (FTSJ1), exerts readthrough activity in vitro and in vivo. |
| PC-20933 |
GSK898
KMO inhibitor
|
GSK898 is a potent, highly selective kynurenine monooxygenase (KMO) inhibitor with pIC50 of 8.8. |
| PC-20931 |
CIN-16645
|
CIN-16645 (LP-01) is an ionizable cationic amino lipid used in combination with other lipids in the formation of lipid nanoparticles (LNPs) to deliver single-guide RNA (sgRNA) targeting MHC class II transactivator (CIITA) in T cells. |
| PC-20930 |
DLin-MC2-DMA
|
DLin-MC2-DMA is an ionizable lipid used for development of lipidoid nanoparticles for siRNA, mRNA, and vaccine delivery. |
| PC-20929 |
DLin-MC4-DMA
|
D-Lin-MC4-DMA is an ionizable lipid used for development of lipidoid nanoparticles for siRNA, mRNA, and vaccine delivery. |
| PC-20927 |
Cantrixil
CAS 2135511-22-5
|
Cantrixil (TRX-E-002-1) is a potent inducer of CD44+/MyD88+ ovarian cancer stem cell (OCSC) death with IC50 of 47 nM. |
| PC-20909 |
GPR56 agonist 36
GPR56 agonist
|
GPR56 agonist 36 is a potent selective agonist of adhesion GPCR ADGRG1/GPR56 with EC50 of 2.95 uM. |
| PC-20902 |
Luvadaxistat
DAAO inhibitor
|
TAK-831 (Luvadaxistat, NBI-1065844) is a highly potent, selective D-amino acid oxidase (DAAO) inhibitor with IC50 of 14 nM against human recombinant DAAO enzyme. |
| PC-20890 |
Lalistat-1
LAL inhibitor
|
Lalistat 1 is a potent and selective lysosomal acid lipase (LAL) inhibitor with IC50 of 68 nM, shows no significant activity against pancreatic lipase or lipoprotein lipase. |
| PC-20889 |
Lalistat-2
LAL inhibitor
|
Lalistat-2 (L-stat) is a specific inhibitor of lysosomal acid lipase (LAL) with IC50 of 152 nM, shows no significant activity against pancreatic lipase or lipoprotein lipase. |
| PC-20883 |
NCI-41356
CRYAB inhibitor
|
NCI-41356 is a small molecular inhibitor of αB-crystallin (CRYAB, HSPB5), significantly reducesthe interaction between CRYAB and VEGF165. |
| PC-20871 |
NVP-231
CerK inhibitor
|
NVP-231 (NVP231) is a potent, specific, and reversible ceramide kinase (CerK) inhibitor with IC50 of 12 nM. |
